首页 › 基金 › Aldebaran Capital, LLC › ACRS
Aldebaran Capital, LLC 对 ACRS 的持仓历史
ACLARIS THERAPEUTICS INC · 医疗保健
Aldebaran Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 ACRS(ACLARIS THERAPEUTICS INC)936,185 股,市值约 US$4.9M,约占其申报组合的 3.54%,在其申报持仓中市值排名第 10 位。 Aldebaran Capital, LLC 最近 10 个申报季度中有 10 个季度披露了 ACRS 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Aldebaran Capital, LLC 对 ACRS 的持仓演变
Aldebaran Capital, LLC 于 Q2 2024 首次披露 ACRS 持仓:858,152 股(约 US$944K)。 该持仓在 Q2 2026 达到峰值 936,731 股,市值约 US$5.0M。 在 10 次申报中,Aldebaran Capital, LLC 1 次增持、7 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 936,185 股、市值约 US$4.9M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 858.15K | $943.97K | 新进 |
| Q3 2024 | 1.04M | $1.20M | 增持 |
| Q4 2024 | 1.02M | $2.52M | 减持 |
| Q1 2025 | 1.01M | $1.54M | 减持 |
| Q2 2025 | 993.70K | $1.41M | 减持 |
| Q3 2025 | 987.70K | $1.88M | 减持 |
| Q4 2025 | 954.26K | $2.87M | 减持 |
| Q1 2026 | 947.16K | $3.55M | 减持 |
| Q2 2026 | 936.73K | $4.96M | 减持 |
| Q3 2026 | 936.18K | $4.92M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ACRS 与 13F 数据
ACRS(ACLARIS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ACRS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ACRS 的基金
- RA CAPITAL MANAGEMENT, L.P. 12.72M 股 · $67.30M · Q2 2026
- BML Capital Management, LLC 10.96M 股 · $57.62M · Q3 2026
- Deep Track Capital, LP 9.35M 股 · $49.44M · Q2 2026
- Vivo Capital, LLC 6.69M 股 · $35.21M · Q3 2026
- Frazier Life Sciences Management, L.P. 4.93M 股 · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M 股 · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M 股 · $21.38M · Q2 2026
- Jones Hill Capital LP 2.50M 股 · $13.17M · Q3 2026
- Kalehua Capital Management LLC 1.83M 股 · $9.64M · Q3 2026
- Palo Alto Investors LP 1.61M 股 · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M 股 · $5.51M · Q2 2026
- Three Bridge Wealth Advisors, LLC 714.82K 股 · $3.76M · Q3 2026
更多关于 Aldebaran Capital, LLC
常见问题
How long has Aldebaran Capital, LLC held ACRS?
Aldebaran Capital, LLC has disclosed ACRS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Aldebaran Capital, LLC's current position in ACRS?
As of Q3 2026, Aldebaran Capital, LLC holds 936.18K shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $4.92M, representing 3.54% of its reported portfolio and ranking #10.
Has Aldebaran Capital, LLC been buying or selling ACRS?
In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC held unchanged its position in ACRS. The position peaked in Q2 2026 at 936.73K shares.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.